Study aim: Determining the effectiveness of acupuncture grief in improving the respiratory symptoms of hospitalized patients with coronavirus Design: A controlled randomized clinical trial, single blinded, phase 3 on 18 patients, using Random Allocation Software for randomization Settings and conduct: Samples include patients with coronavirus who are hospitalized in Ali Asghar Hospital in Shiraz. To blind the clinical evaluator, the study groups are named A and B. Participants/Inclusion and exclusion criteria: Inclusion criteria: The patient's corona virus is approved by PCR test The patient is hospitalized, The patient agrees to participate in the study, The respiratory rate of the patient is more than 30 times per minute, Blood oxygen level should be less than 93%, The patient have pulmonary infiltration according to chest x-ray graph, The patient does not afflict from any serious simultaneous heart, lung, brain, and endocrine disease, Exclusion criteria: The patient suffers from any serious concomitant diseases of the heart, lungs, brain, glands, Patient dissatisfaction with participation in the study, Pregnant and lactating mothers, Existence of any conditions in the patient that, according to the physician's judgment, prevent the continuation of the treatment intervention, Resistant hypoxemia, Hemodynamic instability, Hypercapnia Intervention groups: In intervention group ghamz with needle will be performed at six points LU5, LU7 and SP6, bilaterally for 20 minutes daily for 7 days. In control group sham therapy will be performed at six points LU5, LU7 and SP6, symmetrically on both sides of the body, (points 5 and 7 of the lung path and point 6 of the spleen path) for 20 minutes daily for 7 days. patients in both groups receive conventional medical treatments. Main outcome variables: Vital signs and respiratory symptoms of the patient